Dapagliflozin + Saxagliptin
Composition
This formulation contain combination of Dapagliflozin and Saxagliptin as active agents
Indications
the management of type 2 diabetes mellitus to improve glycemic control in adults
Side effects
urinary tract infections, genital mycotic infections, nasopharyngitis, headache, and hypoglycemia
Precautions
with caution in individuals with a history of urinary tract infections, volume depletion, or renal impairment
Contraindications
individuals with type 1 diabetes mellitus or diabetic ketoacidosis
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai